In a letter from India’s Drugs Controller General, Dr Rajeev Singh Raghuvanshi, the Ministry confirmed that all permissions to manufacture and export these opioids have been revoked. The combination of Tapentadol, a potent opioid, and Carisoprodol, a muscle relaxant banned in Europe for its addictive nature, has been linked to severe health risks, including breathing difficulties, seizures, and fatal overdose.
Also Read: Two Indian companies indicted in US for importing ingredients used in opioid fentanyl
The Indian authorities acted after uncovering that Aveo Pharmaceuticals, alongside its sister company Westfin International, had shipped millions of these harmful pills to West African countries. These opioids are being sold illegally in Nigeria and Côte d’Ivoire, where they have gained popularity due to their affordability and easy availability.
Following this discovery, regulators conducted a raid on Aveo’s Mumbai facility, seizing all stock of the problematic drug combination. Additionally, the Ministry has ordered the withdrawal of Export No-Objection Certificates (NOCs) and revised procedures to prevent further exports of these dangerous drugs. The government’s actions underscore its commitment to ensuring the safety of both domestic and global markets, maintaining strict regulatory oversight to combat the illegal export of unapproved substances.
